全文获取类型
收费全文 | 87287篇 |
免费 | 8692篇 |
国内免费 | 3316篇 |
专业分类
耳鼻咽喉 | 302篇 |
儿科学 | 862篇 |
妇产科学 | 458篇 |
基础医学 | 3783篇 |
口腔科学 | 1038篇 |
临床医学 | 9486篇 |
内科学 | 9000篇 |
皮肤病学 | 1244篇 |
神经病学 | 2908篇 |
特种医学 | 1239篇 |
外国民族医学 | 14篇 |
外科学 | 3316篇 |
综合类 | 11875篇 |
现状与发展 | 6篇 |
一般理论 | 4篇 |
预防医学 | 10300篇 |
眼科学 | 805篇 |
药学 | 32806篇 |
132篇 | |
中国医学 | 5324篇 |
肿瘤学 | 4393篇 |
出版年
2024年 | 398篇 |
2023年 | 1656篇 |
2022年 | 2662篇 |
2021年 | 3497篇 |
2020年 | 3646篇 |
2019年 | 3319篇 |
2018年 | 3301篇 |
2017年 | 3589篇 |
2016年 | 3482篇 |
2015年 | 3446篇 |
2014年 | 5970篇 |
2013年 | 8948篇 |
2012年 | 5892篇 |
2011年 | 6027篇 |
2010年 | 4779篇 |
2009年 | 4341篇 |
2008年 | 4024篇 |
2007年 | 4040篇 |
2006年 | 3604篇 |
2005年 | 3119篇 |
2004年 | 2665篇 |
2003年 | 2359篇 |
2002年 | 1810篇 |
2001年 | 1724篇 |
2000年 | 1346篇 |
1999年 | 1183篇 |
1998年 | 1025篇 |
1997年 | 929篇 |
1996年 | 780篇 |
1995年 | 694篇 |
1994年 | 624篇 |
1993年 | 512篇 |
1992年 | 578篇 |
1991年 | 472篇 |
1990年 | 374篇 |
1989年 | 311篇 |
1988年 | 309篇 |
1987年 | 280篇 |
1986年 | 237篇 |
1985年 | 251篇 |
1984年 | 212篇 |
1983年 | 147篇 |
1982年 | 132篇 |
1981年 | 111篇 |
1980年 | 91篇 |
1979年 | 67篇 |
1978年 | 86篇 |
1977年 | 58篇 |
1976年 | 53篇 |
1975年 | 58篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Ole Rogeberg 《Addiction (Abingdon, England)》2020,115(1):184-187
The Theory of Rational Addictions, by Gary Becker & Kevin Murphy (1988), was a rational choice model that became a standard tool for economists modeling addictive behavior. The approach differs from other theories of addiction by modeling addictive behavior as the gradual implementation of a rational, forward‐looking plan, where consumption at any point in time is partly motivated by the immediate payoff of consumption and partly by the effects this consumption has on the individual in the future. This makes addictive behavior a subset of rational behavior, requiring no more specific government policies or attention than any other consumption choice. Later work by economists extended the theory in different ways, allowing it to match an increasing number of consumption patterns, and searched for ways to test the forward‐looking assumption in different types of market data. While the work was successful as a contribution to rational choice theory, with possible statistical applications, there are several reasons to dismiss its usefulness as an explanation of real‐world addictive behavior and its ability to assess the welfare effects of addictions. 相似文献
3.
4.
5.
Cristiano Colalto 《Drug development research》2020,81(8):950-968
COVID-19 is a novel coronavirus disease with a higher incidence of bilateral pneumonia and pleural effusion. The high pulmonary tropism and contagiousness of the virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have stimulated new approaches to combat its widespread diffusion. In developing new pharmacological strategies, the chemical characteristic of volatility can add therapeutic value to the hypothetical drug candidate. Volatile molecules are characterized by a high vapor pressure and are consequently easily exhaled by the lungs after ingestion. This feature could be exploited from a pharmacological point of view, reaching the site of action in an uncommon way but allowing for drug delivery. In this way, a hypothetical molecule for COVID-19 should have a balance between its lung exhalation characteristics and both antiviral and anti-inflammatory pharmacological action. Here, the feasibility, advantages, and disadvantages of a therapy based on oral administration of possible volatile drugs for COVID-19 will be discussed. Both aerosolized antiviral therapy and oral intake of volatile molecules are briefly reviewed, and an evaluation of 1,8-cineole is provided in view of a possible clinical use and also for asymptomatic COVID-19. 相似文献
6.
利用空间频域成像技术搭建的成像系统检测多种皮肤病组织的光学参数和生理参数信息,并对比分析讨论不同类型的皮肤病与光学参数、生理参数之间的关系。实验结果表明,病变皮肤组织与正常皮肤组织之间在光学参数、生理参数上存在较大差异,这将为临床医生对皮肤病诊治提供一种新颖、可靠、科学的评估方法。 相似文献
7.
8.
《Value in health》2020,23(8):1027-1033
ObjectivesIn many countries, future unrelated medical costs occurring during life-years gained are excluded from economic evaluation, and benefits of unrelated medical care are implicitly included, leading to life-extending interventions being disproportionately favored over quality of life-improving interventions. This article provides a standardized framework for the inclusion of future unrelated medical costs and demonstrates how this framework can be applied in England and Wales.MethodsData sources are combined to construct estimates of per-capita National Health Service spending by age, sex, and time to death, and a framework is developed for adjusting these estimates for costs of related diseases. Using survival curves from 3 empirical examples illustrates how our estimates for unrelated National Health Service spending can be used to include unrelated medical costs in cost-effectiveness analysis and the impact depending on age, life-years gained, and baseline costs of the target group.ResultsOur results show that including future unrelated medical costs is feasible and standardizable. Empirical examples show that this inclusion leads to an increase in the ICER of between 7% and 13%.ConclusionsThis article contributes to the methodology debate over unrelated costs and how to systematically include them in economic evaluation. Results show that it is both important and possible to include future unrelated medical costs. 相似文献
9.
目的比较3%高渗盐水和20%甘露醇治疗重症动脉瘤性蛛网膜下腔出血所致颅内压增高的疗效.方法25例动脉瘤性蛛网膜下腔出血患者出现颅内压增高事件时, 随机交替接受等渗透剂量的160 mL 3%高渗盐水与150 mL 20%甘露醇进行降低颅内压治疗, 连续监测患者颅内压、平均动脉压、脑灌注压及中心静脉压.记录有效降低颅内压持续时间、颅内压最大降幅及其时间, 用药前及用药后1 h、3 h血钠水平及血浆渗透压.结果3%高渗盐水和20%甘露醇均可降低颅内压(均 P < 0.01), 两者的降低颅内压作用持续时间及颅内压降幅差异均无统计学意义(均 P >0.05).患者脑灌注压较用药前均上升(均 P < 0.01), 平均动脉压先上升后下降, 但差异无统计学意义( P >0.05).患者中心静脉压稍有波动, 但差异均无统计学意义(均 P >0.05).20%甘露醇治疗后患者血钠下降, 3%高渗盐水治疗后患者血钠值上升, 变化均有统计学意义(均 P < 0.05).20%甘露醇及3%高渗盐水治疗后患者血浆渗透压均先上升后下降, 变化均有统计学意义(均 P < 0.01). 结论3%高渗盐水可作为治疗动脉瘤性蛛网膜下腔出血所致颅内压增高患者的一线治疗药物. 相似文献
10.
2015年中华医学会感染病学分会艾滋病学组发布了第三版《艾滋病诊疗指南》。新版指南强调抗病毒治疗时点前移:一旦成人确诊感染人类免疫缺陷病毒(HIV), 若无禁忌宜尽早启动抗HIV治疗。对于合并机会性感染的HIV感染者, 在感染控制、病情稳定后也应及早开始抗病毒治疗。尤其强调HIV合并结核患者在CD4阳性淋巴细胞数少于200/μL的情况下, 建议抗结核两周内即开始抗病毒治疗。在抗HIV治疗用药中, 淘汰了一些毒副作用大、依从性较差的药物, 如司他夫定、去羟肌苷、茚地那韦等, 优选抗病毒效力强、服药方便的组合, 如拉米夫定、替诺福韦、依非韦伦组合。对于HIV感染的婴幼儿, 亦主张及早抗HIV治疗。对于五岁以内的幼儿, 主张确诊后即启动抗病毒治疗。对于HIV感染的孕产妇, 建议尽快予以全程、联合抗HIV治疗, 寓防于治。 相似文献